Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARTA spondyloarthritis remission trial after anti-TNF discontinuation
2007-001694-28Phase 4Terminated
- Sponsor
- Department of Rheumatology, Hvidovre Hospital
- Start
- Apr 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of adalimumab, etanercept and infliximab in spondyloarthritis (SpA) and ankylosing spondylitis (AS) (2 arms), sponsored by Department of Rheumatology, Hvidovre Hospital. Primary endpoint: Disease flare. Started Apr 2007; status: terminated.
02
Drugs
03
Conditions
spondyloarthritis (SpA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2007-001694-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001694-28.